ACTRN12605000394640
招募中
4 期
Treatment of Schizophrenia with Aripiprazole. A one year open-label study examining an ultraslow switchover regime to minimise relapse and withdrawal symptoms.
Associate Professor Krishna Vaddadi0 个研究点目标入组 40 人2005年9月14日
概览
- 阶段
- 4 期
- 干预措施
- 未指定
- 疾病 / 适应症
- Schizophrenia
- 发起方
- Associate Professor Krishna Vaddadi
- 入组人数
- 40
- 状态
- 招募中
- 最后更新
- 6年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •Patients who are outpatients (private or public) attending southern health facility and have a well established diagnosis of schizophrenia (DSM\-IV diagnosis criteria), who report side effects on their existing medication, who have not fully responded to their current therapy, who in the clinicians opinion, would benefit from Aripiprazole, who are able to comprehend what is happening to them and able to give informed consent, who can speak a reasonable level of English, and where completing rating scales with adequate information is not a practical problem.
排除标准
- •Patients who want to become pregnant during the study period, with alcohol dependence, with acquired brain injury associated with schizophrenia, who are on too complex medication regimes which would be difficult to change, who have previously been treated with Aripiprazole, who are on very high doses of clozapine in (\>500mg/day), on very high doses of injectable Zuclopenthixol Decanoate (\>200mg/fortnight), with a past history of severe violence/suicidal risk, who are generally non\-compliant with oral medication, who have poor social supports and are very unreliable with appointments, and patients who are very stable on their current antipsychotic medication, but want to change to Aripiprazole simply because it is a new drug, their friend got better or, someone told them it is a good idea.
结局指标
主要结局
未指定
相似试验
已完成
不适用
Aripiprazole research over schizophrenia patients (both on first episode and recurrence) about its efficacy and influence on cognitive functioschizophreniaJPRN-UMIN000002076Kyoto University Hospital20
尚未招募
不适用
Aripiprazole dose reduction in stable schizophreniaJPRN-UMIN000051193Keio University100
已完成
4 期
Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social AnxietySchizophreniaSchizoaffective DisorderSocial Anxiety DisorderNCT00177008University of Medicine and Dentistry of New Jersey18
已完成
1 期
Efficacy of Aspirin in the treatment of schizophreniaSchizophrenia.Schizophrenia, schizotypal and delusional disorders.IRCT201108197373N1Arak University Of Medical Sciences60
已完成
不适用
Efficacy and Safety of Aripiprazole in Patients With Schizophrenia or Bipolar DisorderSchizophreniaBipolar DisorderNCT00216723Korea Otsuka Pharmaceutical Co., Ltd.3,000